×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Press Release

View printer-friendly version
Amgen Announces Webcast of 2005 Fourth Quarter and Full Year Financial Results

THOUSAND OAKS, Calif., Jan 09, 2006 (BUSINESS WIRE) -- Amgen (Nasdaq:AMGN), the world's largest biotechnology company, today announced plans to report 2005 fourth quarter and full year financial results on Thursday, January 26, 2006, before the opening of the financial markets. The announcement will be followed by a live conference with the investment community at 8 a.m. Eastern Standard Time.

Participating in the event from Amgen will be Kevin Sharer, chairman and chief executive officer, and other members of Amgen's senior management team.

The conference will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. The event, including the question and answer session, is expected to last approximately two hours.

The webcast of the conference can be found on www.amgen.com by clicking on Investors. A link to the webcast is under the Events header. The webcast will be archived and available for replay 72 hours after the event.

About Amgen

Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a broad and deep pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

SOURCE: Amgen

Amgen, Thousand Oaks
Christine Cassiano, 805-447-4587 (media)
Arvind Sood, 805-447-1060 (investors)